The active peptide structure breaks down when exposed to temperatures above 46F, potentially rendering your dose less potent or unsafe
But, when a product is in shortage, licensed pharmacies and FDA-registered compounding facilities are permitted to manufacture versions of the FDA-approved product that are essentially a copy of the FDA-approved product until the shortage is resolved
doi: 10.1007/s40520-018-0910-4 [DOI] [PubMed] [Google Scholar] 24.Mahmud N, Serper M, Taddei TH, Kaplan DE
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related alzheimers disease by exendin-4
The tirzepatide first month guide covers what to expect in the critical initial period
An estimated 51.3% of MASLD patients are obese, and the percentage rises to 81.8% in MASH, 22 with approximately 1020% categorized as lean MASLD